SOLVENTUM CORPORATION Deferred Revenue Recognized
SOLVENTUM CORPORATION (SOLV) reported Deferred Revenue Recognized of $189.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-08-05
- SOLVENTUM CORPORATION contract with customer, liability, revenue recognized for the quarter ending 2026-06-30 was $189.00M, a 18.87% increase year-over-year.
- SOLVENTUM CORPORATION contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $226.00M, a 2.73% increase year-over-year.
- SOLVENTUM CORPORATION contract with customer, liability, revenue recognized for the quarter ending 2025-09-30 was $98.00M, a 10.91% decline year-over-year.
- SOLVENTUM CORPORATION contract with customer, liability, revenue recognized for the quarter ending 2025-06-30 was $159.00M, a 6.00% increase year-over-year.
- SOLVENTUM CORPORATION contract with customer, liability, revenue recognized for fiscal 2025 was $550.00M, a 0.00% change from fiscal 2024.
- SOLVENTUM CORPORATION contract with customer, liability, revenue recognized for fiscal 2024 was $550.00M, a 1.85% increase from fiscal 2023.
- SOLVENTUM CORPORATION contract with customer, liability, revenue recognized for fiscal 2023 was $540.00M, a 0.00% change from fiscal 2022.
- SOLVENTUM CORPORATION contract with customer, liability, revenue recognized for fiscal 2022 was $540.00M.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $189.00M 10-Q · filed 2026-08-05 | $416.00M 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | $226.00M 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | $550.00M 10-K · filed 2026-02-27 | |||
| 2025-09-30 | $98.00M 10-Q · filed 2025-11-06 | $477.00M 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $159.00M 10-Q · filed 2026-08-05 | $379.00M 10-Q · filed 2026-08-05 | ||
| 2025-03-31 | $220.00M 10-Q · filed 2026-05-05 | |||
| 2024-12-31 | $550.00M 10-K · filed 2026-02-27 | |||
| 2024-09-30 | $110.00M 10-Q · filed 2025-11-06 | $500.00M 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $150.00M 10-Q · filed 2025-08-08 | $390.00M 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | $240.00M 10-Q · filed 2025-05-09 | |||
| 2023-12-31 | $540.00M 10-K · filed 2026-02-27 | |||
| 2023-09-30 | $115.00M 10-Q · filed 2024-11-08 | $475.00M 10-Q · filed 2024-11-08 | ||
| 2023-06-30 | $155.00M 10-Q · filed 2024-08-09 | $360.00M 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $205.00M 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | $540.00M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |